Delivery Order SPE2DB22D3401-SPE2DB25FT3PE
Award Date
5/9/25
Potential Completion Date
5/12/25
Potential Value
$7.5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $7,320.67, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of ACTEMRA ACTPEN 162 MG/0.9 ML 0.9ML, a medical product, with a performance period through May 2025. Amerisourcebergen Drug Corp is the prime contractor on this contract, which is not designated as a set-aside. The company holds a larger Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,843.19 firm fixed price delivery order contract covers the supply of ACTEMRA ACTPEN 162 MG/0.9 ML 0.9ML, a specialty medication. The contract has an ultimate completion date of March 18, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award, valued at $51,988.40, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is a delivery order contract for the supply of the medication ACTEMRA ACTPEN 162 MG/0.9 ML 0.9ML. The contract is a firm fixed-price, non-set-aside award with a performance period through May 8, 2025. Amerisourcebergen Drug Corp also holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,581.18 firm-fixed-price delivery order is for the supply of ACTEMRA ACTPEN 162 MG/0.9 ML 0.9ML, a specialty medication. The contract has an ultimate completion date of November 4, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,150.35, is a delivery order for the medication Actemra Actpen 162 mg/0.9 ml. The contract is not set aside and is a firm fixed-price delivery order. Amerisourcebergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is the prime contractor. This award is part of a larger $999,999,999.00...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $10,870.66, is for the delivery of 162 mg/0.9 mL Actemra syringes. This is a firm-fixed price delivery order contract with an ultimate completion date of October 16, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, worth up to $999,999,999, which...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract, valued at $13,987.43, is for the delivery of ACTEMRA ACTPEN 162 MG/0.9 ML 0.9ML, a pharmaceutical product, with an ultimate completion date of April 1, 2025. The contract is a Firm Fixed Price Delivery Order and is not set aside for any specific business type. Amerisourcebergen Drug Corp is the prime...
This federal contract award, valued at $1,375.80, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. The contract is for the delivery of ACTEMRA ACTPEN 162 MG/0.9 ML 0.9ML, a pharmaceutical product, with a completion date of December 6, 2024. The contract is a Delivery Order under a Firm Fixed Price arrangement, and it does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare...
This $5,755.68 firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order (SPE2DB25FN7P6) from the Defense Logistics Agency (DLA) with a ceiling value of $9,971.78. The contract is for the delivery of the prescription medication ACTEMRA ACTPEN 162 MG/0.9 ML 0.9ML. There is no set-aside designation, indicating open competition. The ultimate completion date is May 12, 2025. Amerisourcebergen Drug Corp also holds a significant Indefinite Delivery Contract...